Business Trends

Apr 19, 2018
By BioPharm International Editors
The transaction is part of Merck KGaA’s strategy to actively shape its product portfolio and focus on innovation-driven business.
Apr 19, 2018
By BioPharm International Editors
Global investment firm Advent to acquire and invest in Sanofi’s European generics business, Zentiva, to boost its position in European market.
Apr 17, 2018
By BioPharm International Editors
Industry experts will discuss lyophilization best practices and continuous manufacturing for biopharmaceuticals.
Apr 11, 2018
By BioPharm International Editors
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.
Apr 01, 2018
BioPharm International
More diversified therapies and tighter payer budgets will challenge bio/pharma companies to think outside the industry.
Mar 30, 2018
By BioPharm International Editors
The company’s close communication with customers has enabled it to bring advanced pipetting products to market.
Mar 29, 2018
By BioPharm International Editors
The acquisition strengthens Celgene’s position in the global cellular immunotherapy space.
Mar 28, 2018
By BioPharm International Editors
Takeda is considering approaching Shire with a possible offer.
Mar 27, 2018
By BioPharm International Editors
In a $13-billion transaction, GSK will purchase Novartis’ share of the Consumer Healthcare Joint Venture.
Mar 19, 2018
By BioPharm International Editors
The companies intend to jointly develop and commercialize Lenvima (lenvatinib mesylate) as a monotherapy and an in-combination therapy for treating multiple cancer types.
native1_300x100
lorem ipsum